RxFunction®, Inc., a pioneering medical device company dedicated to enhancing patient mobility and confidence, has successfully raised an impressive $16.5 million in funding. This capital injection will enable the company to accelerate the growth and distribution of its flagship product, Walkasins® Lower Limb Sensory Prosthesis. Clinically proven to enhance gait and balance while significantly reducing the risk of falls, Walkasins serves individuals experiencing numbness in their feet due to peripheral neuropathy. By effectively replacing some of the lost nerve function, this innovative device directly addresses the mobility challenges faced by such patients.
Founded on the groundbreaking patented technology created by co-founder and scientist Lars Oddsson, PhD, RxFunction has made significant strides in the medical technology sector, supported in part by Small Business Innovation Research grants from the National Institutes of Health. Manufactured in Minnesota, Walkasins is the only product of its kind available by prescription, underscoring RxFunction’s commitment to improving quality of life for those with mobility impairments. With this new funding, RxFunction plans to expand its research and development efforts, enhance marketing initiatives, and ultimately reach a broader clientele in need of advanced mobility solutions. As the company continues to innovate and refine its product offerings, it remains dedicated to its mission of empowering patients to reclaim their independence and confidence in daily activities. For more information about Walkasins and its groundbreaking technology, visit www.rxfunction.com.
